Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Milione

Showing results (61-70 of 206) with videos related to

Pageof 21
Sort By:
Cancers|March 29, 2023
Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant ChemoradiotherapyLuca Sorrentino, Annaclara Sileo, Elena Daveri, et al.
Annals of Surgical Oncology|August 14, 2016
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal MetastasesDario Baratti, Shigeki Kusamura, Domenico Iusco, et al.
Tumori|October 28, 2009
Pitfalls in the diagnosis of neuroendocrine tumors: atypical clinical and radiological findings as cause of medical mistakesEmilio Bajetta, Laura Catena, Monika Ducceschi, et al.
Expert Review of Anticancer Therapy|June 30, 2016
Update on medical treatment of small intestinal neuroendocrine tumorsSara Pusceddu, Daniela Femia, Giuseppe Lo Russo, et al.
Future Oncology (London, England)|July 11, 2015
Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic reviewSara Pusceddu, Filippo De Braud, Fabrizio Festinese, et al.
Neuroendocrinology|November 1, 2008
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomasVito D Corleto, Massimo Falconi, Francesco Panzuto, et al.
Tumori|August 18, 2018
Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center studyStefano Signoroni, Maria Grazia Tibiletti, Maria Teresa Ricci, et al.
Molecular Oncology|October 31, 2015
Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cellsFrancesca Andriani, Giulia Bertolini, Federica Facchinetti, et al.
Tumori|May 2, 2018
Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledgeSara Pusceddu, Natalie Prinzi, Alessandra Raimondi, et al.
Critical Reviews in Oncology/Hematology|June 2, 2023
Digestive MiNENs: Could histological classification and molecular characterization drive clinical outcome and therapeutic approach?Laura Cattaneo, Giovanni Centonze, Giovanna Sabella, et al.
Pageof 21

Showing results (61-70 of 206) with videos related to

Sort By:
Pageof 21
Cancers|March 29, 2023
Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant ChemoradiotherapyLuca Sorrentino, Annaclara Sileo, Elena Daveri, et al.
Annals of Surgical Oncology|August 14, 2016
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal MetastasesDario Baratti, Shigeki Kusamura, Domenico Iusco, et al.
Tumori|October 28, 2009
Pitfalls in the diagnosis of neuroendocrine tumors: atypical clinical and radiological findings as cause of medical mistakesEmilio Bajetta, Laura Catena, Monika Ducceschi, et al.
Expert Review of Anticancer Therapy|June 30, 2016
Update on medical treatment of small intestinal neuroendocrine tumorsSara Pusceddu, Daniela Femia, Giuseppe Lo Russo, et al.
Future Oncology (London, England)|July 11, 2015
Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic reviewSara Pusceddu, Filippo De Braud, Fabrizio Festinese, et al.
Neuroendocrinology|November 1, 2008
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomasVito D Corleto, Massimo Falconi, Francesco Panzuto, et al.
Tumori|August 18, 2018
Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center studyStefano Signoroni, Maria Grazia Tibiletti, Maria Teresa Ricci, et al.
Molecular Oncology|October 31, 2015
Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cellsFrancesca Andriani, Giulia Bertolini, Federica Facchinetti, et al.
Tumori|May 2, 2018
Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledgeSara Pusceddu, Natalie Prinzi, Alessandra Raimondi, et al.
Critical Reviews in Oncology/Hematology|June 2, 2023
Digestive MiNENs: Could histological classification and molecular characterization drive clinical outcome and therapeutic approach?Laura Cattaneo, Giovanni Centonze, Giovanna Sabella, et al.
Pageof 21